A Study of OT-101 With mFOLFIRINOX in Patients With Advanced and Unresectable or Metastatic Pancreatic Cancer

Clinical trial NCT06079346 · RECRUITING

Trial details

NCT number: NCT06079346
Sponsor: Oncotelic Inc.
Status: RECRUITING
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Pancreatic Ductal Adenocarcinoma

Start date: 2024-05-01
Primary completion: 2026-06-01
Enrollment: 455

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.